Perillaldehyde is a new ferroptosis inducer with a relevant clinical potential for acute myeloid leukemia therapy
Elena Catanzaro(Ghent University), Carmela Fimognari(University of Bologna)
Cited by 29
Related Papers
Natural Products to Fight Cancer: A Focus on Juglans regia
|Toxins|2018|66
Balanced dual acting compounds targeting aromatase and estrogen receptor α as an emerging therapeutic opportunity to counteract estrogen responsive breast cancer
|European Journal of Medicinal Chemistry|2021|23
Marine-Derived Compounds Targeting Topoisomerase II in Cancer Cells: A Review
|Marine Drugs|2022|8
Novel Insights in the Potential of Halogenated Polyketide–Peptide Molecules as Lead Compounds in Cancer Drug Discovery
|International Journal of Molecular Sciences|2023|2